T094. HPV Molecular Testing and the Role of Genotyping
Date: March 24, 2010
Speaker: Aaron Bossler

Summary of Session: This presentation will review the clinical importance of high risk HPV infection, the current recommendations for HPV testing and the different options that are available and in development for HPV molecular testing.

Objectives: Upon completion of this Teleconference, participants should be able to:

• Explain the importance of high risk HPV detection in managing women with abnormal cytology results.
• Describe the utility of HPV genotyping.
• Compare and contrast the different molecular testing assays.

Intended Audience: This teleconference is intended for molecular, microbiology, and cytology lab directors and technologists.

CME Disclosures: The Presenter has nothing to disclose.

Termination of CME Credit: This program will not be eligible for CME credit after March 24, 2011